Jianmin Pharmaceutical Group Co Ltd (600976) — Cash Flow-to-Debt Ratio
Jianmin Pharmaceutical Group Co Ltd (600976) has a Cash Flow-to-Debt Ratio of 0.06x as of December 2025, meaning its operating cash flow of CN¥106.82 Million could theoretically repay 0% of its total liabilities (CN¥1.81 Billion) in one year. See free cash flow generation of Jianmin Pharmaceutical Group Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Jianmin Pharmaceutical Group Co Ltd Cash Flow-to-Debt Ratio (2003–2025)
Historical debt coverage capacity for Jianmin Pharmaceutical Group Co Ltd across 23 annual periods. Also explore Jianmin Pharmaceutical Group Co Ltd net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Jianmin Pharmaceutical Group Co Ltd (2003–2025)
Year-by-year debt coverage analysis for Jianmin Pharmaceutical Group Co Ltd. For market capitalisation and broader financial context, see 600976 market cap.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.15x | CN¥274.53 Million | CN¥1.81 Billion | ▲ +18.6% |
| 2024 | 0.13x | CN¥234.27 Million | CN¥1.83 Billion | ▼ -8.7% |
| 2023 | 0.14x | CN¥268.39 Million | CN¥1.91 Billion | ▲ +2.1% |
| 2022 | 0.14x | CN¥215.87 Million | CN¥1.57 Billion | ▼ -33.3% |
| 2021 | 0.21x | CN¥259.18 Million | CN¥1.26 Billion | ▲ +79.6% |
| 2020 | 0.11x | CN¥125.54 Million | CN¥1.09 Billion | ▲ +11.1% |
| 2019 | 0.10x | CN¥74.45 Million | CN¥720.63 Million | ▼ -6.3% |
| 2018 | 0.11x | CN¥63.60 Million | CN¥577.11 Million | ▲ +155.7% |
| 2017 | 0.04x | CN¥35.20 Million | CN¥816.71 Million | ▼ -70.6% |
| 2016 | 0.15x | CN¥113.84 Million | CN¥776.45 Million | ▲ +83.0% |
| 2015 | 0.08x | CN¥48.45 Million | CN¥604.72 Million | ▼ -57.7% |
| 2014 | 0.19x | CN¥103.23 Million | CN¥544.79 Million | ▲ +110.9% |
| 2013 | 0.09x | CN¥45.36 Million | CN¥504.92 Million | ▼ -67.3% |
| 2012 | 0.27x | CN¥98.17 Million | CN¥357.90 Million | ▲ +205.8% |
| 2011 | -0.26x | CN¥-75.54 Million | CN¥291.28 Million | ▼ -139.5% |
| 2010 | 0.66x | CN¥150.08 Million | CN¥228.78 Million | ▲ +368.0% |
| 2009 | 0.14x | CN¥66.69 Million | CN¥475.79 Million | ▼ -49.4% |
| 2008 | 0.28x | CN¥110.11 Million | CN¥397.80 Million | ▲ +675.4% |
| 2007 | -0.05x | CN¥-6.88 Million | CN¥143.07 Million | ▼ -124.4% |
| 2006 | 0.20x | CN¥56.18 Million | CN¥285.18 Million | ▲ +271.4% |
| 2005 | -0.11x | CN¥-34.63 Million | CN¥301.33 Million | ▼ -710.1% |
| 2004 | 0.02x | CN¥4.13 Million | CN¥219.38 Million | ▲ +9.0% |
| 2003 | 0.02x | CN¥4.19 Million | CN¥242.31 Million | — |